High-sensitive Troponin: A new tool for clinical decision-making in valvular heart disease?
Given the demographic changes in the western hemisphere, heart disease epidemiology is undergoing a substantial change. During the next decades, we will face an enormous rise of valvular heart disease (VHD) patients with a need for treatment [1]. In particular, the fraction of typical age-associated VHDs such as aortic stenosis and mitral regurgitation will continue to increase.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Johanne Frank, Norbert Frey, Derk Frank Source Type: research